Advertisement
Canada markets closed
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7296
    -0.0002 (-0.03%)
     
  • CRUDE OIL

    82.80
    -0.01 (-0.01%)
     
  • Bitcoin CAD

    87,917.02
    -2,903.93 (-3.20%)
     
  • CMC Crypto 200

    1,384.80
    -39.30 (-2.76%)
     
  • GOLD FUTURES

    2,330.10
    -8.30 (-0.35%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,472.25
    -192.25 (-1.09%)
     
  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     
  • FTSE

    8,040.38
    -4.43 (-0.06%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • CAD/EUR

    0.6818
    -0.0001 (-0.01%)
     

Five Star Equities Issues New Research Reports on ATHN, AVEO, EW and QSII

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

Athenahealth, Inc. (NASDAQ:ATHN - News) shares surged 109.75 percent to close at $109.75 a share Friday. The stock traded between $103.36 and $110.00 on volume of 3.21 million shares traded. The company announced that it has a signed a significant deal with Clinical Holdings, Ascension Health Network’s physician services segment. Shares of Athenahealth have gained approximately 50.0 percent year-to-date.

Get more information on Athenahealth and free access to the in-depth equity report at:
www.FiveStarEquities.com/ATHN

AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO - News) shares gained 0.39 percent to close at $2.55 a share Friday. The stock traded between $2.23 and $2.56 on volume of 1.17 million shares traded. The company has received a subpoena from the U.S. Securities and Exchange Commission for documents related to its experimental kidney cancer drug. Shares of AVEO Pharmaceuticals have fallen approximately 68.3 percent year-to-date.

ADVERTISEMENT

Get more information on AVEO Pharmaceuticals and free access to the in-depth equity report at:
www.FiveStarEquities.com/AVEO

Edwards Lifesciences Corp. (NYSE:EW - News) shares jumped 3.13 percent to close at $67.85 a share Friday. The stock traded between $67.10 and $69.14 on volume of 2.24 million shares traded. The company announced that the District Court of Mannheim, Germany, has found that Medtronic infringed Edwards' Spenser patent for transcatheter heart valve technology. Shares of Edwards Lifesciences have fallen approximately 24.75 percent year-to-date.

Get more information on Edwards Lifesciences and free access to the in-depth equity report at:
www.FiveStarEquities.com/EW

Quality Systems, Inc. (NASDAQ:QSII - News) shares spiked 12.12 percent to close at $22.39 a share Friday. The stock traded between $20.51 and $22.56 on volume of 1.90 million shares traded. Robert W. Baird has recently upgraded the company’s rating to “outperform” from “neutral”. Shares of Quality Systems have gained approximately 29.0 percent year-to-date.

Get more information on Quality Systems and free access to the in-depth equity report at:
www.FiveStarEquities.com/QSII

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Five Star Equities
info@fivestarequities.com